Project: Developing and validating diagnostic tools for tight monitoring of Inflammatory Arthritis patients

We intend to develop diagnostic tools which allow Health Care Professionals (HCP) to monitor the status of inflammation and drug response in capillary blood of patients with Inflammatory Arthritis (I.A.) at the point-of-care. We will deliver a menu of fully quantitative lateral flow immunoassays to measure a) inflammation biomarkers, b) therapeutic drug concentrations, c) antibodies to therapeutic drugs, d) technology concepts for the simple and safe collection and processing of capillary blood.

Acronym	opTIMISm (Reference Number: 10684)
Duration	01/10/2016 - 01/10/2019
Project Topic	Biological Sciences / Technologies
Network	Eurostars 2
Call	Eurostars Cut-Off 5

Project partner

Number	Name	Role	Country
24900	BÜHLMANN Laboratories AG	Coordinator	Switzerland
24901	Milenia Biotec GmbH	Partner	Germany
24902	Westfälische Wilhelms-Universität Münster - Universitätsklinikum Münster	Partner	Germany